Dice CEO: Energy, T...
Health Care: Drugs
Alexza Pharmaceuticals Inc. (ALXA: NASDAQ)
$0.36 0.00 | -1.37%
06/01/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 5.66M | 42.88M | 9.51M | 486.00K |
| Cost of Sales | -5.24M | -5.04M | -4.98M | -5.29M |
| Gross Operating Profit | 10.90M | 47.91M | 14.49M | 5.78M |
| Selling, General, and Administrative Expenses | 11.77M | 14.00M | 15.41M | 17.64M |
| Research & Development | 28.26M | 33.53M | 39.78M | 61.56M |
| Operating Income before D & A (EBITDA) | -29.13M | 384.00K | -40.69M | -73.43M |
| Depreciation & Amortization | 5.24M | 5.04M | 4.98M | 5.29M |
| Interest Income | 26.00K | 35.00K | 92.00K | 2.61M |
| Other Income - Net | -4.00M | 4.77M | -69.55M | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -38.34M | 151.00K | -117.16M | -76.11M |
| Interest Expense | 2.19M | 1.63M | 467.00K | 935.00K |
| Pre-Tax Income | -40.53M | -1.48M | -117.63M | -77.04M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | -13.99M | -18.59M |
| Net Income From Continuing Operations | -40.53M | -1.48M | -103.64M | -58.45M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -40.53M | -1.48M | -103.64M | -58.45M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -40.53M | -1.48M | -103.64M | -58.45M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-40.53M | -1.48M | -101.61M | -58.45M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -40.53M | -1.48M | -103.64M | -58.45M |
| Basic EPS from Continuing Ops. | -0.60 | -0.03 | -2.68 | -1.81 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.60 | -0.03 | -2.68 | -1.81 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.60 | -0.03 | -2.68 | -1.81 |
| Basic Normalized Net Income/Share | -0.60 | -0.03 | -2.63 | -1.81 |
| EPS fr Continuing Ops. | -0.60 | -0.03 | -2.68 | -1.81 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.60 | -0.03 | -2.68 | -1.81 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.60 | -0.03 | -2.68 | -1.81 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.60 | -0.03 | -2.63 | -1.81 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ALXA
- Portfolio NameUser Type
- Uservlady 1
- ContributorStocks With Big Insider Buy...
- UserSMITTY
- ContributorBarron's Insider Purchases ...
- UserHi Potential
- UserRAPTOR SPRTD RED-03110081643
- UserScottrade 20K
- UserBburn Portfolio 1
- UserRatBastard Portfolio 1
- Userpornholio
Latest ALXA Headlines from TheStreet
- Friday's Top 10 Articles, Videos on TheStreet 05.04.12 | 01:05 pm
- Alexza Stock Gaps Down On Today's Open (ALXA) 05.04.12 | 09:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- 26 Drugs Facing FDA Approval in 2012 05.02.12 | 01:05 pm
- The Next Big Thing In Biotech: Alexza
04.13.12 | 06:04 am - Alexza Pharmaceuticals Inc. Stock Downgraded (ALXA) 02.24.12 | 05:02 am
- Alexza Stock Gaps Down On Today's Open (ALXA) 02.17.12 | 08:02 am
- 5 Stocks Insiders Are Loading Up On 01.26.12 | 12:01 pm
- Alexza Stock Gaps Up On Today's Open (ALXA) 01.03.12 | 11:01 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
Press Releases for ALXA
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Alexza Pharmaceuticals Inc. - PR Newswire 05.07.12 | 08:05 am
- Alexza And Grupo Ferrer Amend Adasuve⢠Partnership - PR Newswire 03.07.12 | 04:03 pm
- Alexza To Announce 2011 Year-End Financial Results On Monday, March 12, 2012 - PR Newswire 03.05.12 | 09:03 am
- Alexza Prices $22 Million Public Offering - PR Newswire 02.17.12 | 07:02 am
- Alexza Announces Proposed Public Offering Of Common Stock And Warrants - PR Newswire 02.16.12 | 06:02 pm
- Alexza Pharmaceuticals Receives Day 80 Assessment Report For ADASUVE (Staccato® Loxapine) MAA - PR Newswire 02.13.12 | 08:02 am
- Alexza Retains Lazard To Explore Strategic Options - PR Newswire 12.16.11 | 08:12 pm
- FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval Of Alexza's ADASUVE⢠- PR Newswire 12.13.11 | 05:12 am
- Alexza Pharmaceuticals To Present At The Lazard Capital Markets 8th Annual Healthcare Conference - PR Newswire 11.02.11 | 09:11 am
- Alexza To Announce 2011 Third Quarter Financial Results On Monday, November 7, 2011 - PR Newswire 10.27.11 | 06:10 pm
Partner Headlines for ALXA
- Benzinga's Microcap Movers for Friday May 4, 2012 - Benzinga 05.05.12 | 12:05 pm
- 6 Biotech Stocks With Huge Potential In May - Seeking Alpha 04.11.12 | 08:04 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- Alexza and Grupo Ferrer Amend Adasuve Partnership Alexza and Grupo Ferrer Amend Adasuve Partnership; Ferrer to Purchase 2.42M Shares of Alexza Common Stock for $1.24 per Share - Benzinga 03.07.12 | 04:03 pm
- Analysis Of Institutional 5% Ownership Filings On Tuesday And Wednesday - Seeking Alpha 01.05.12 | 08:01 am
- Microcap Movers for Friday December 9, 2011 - Benzinga 12.09.11 | 06:12 pm
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Company News for October 5, 2011 - Corporate Summary - Zacks 10.05.11 | 10:10 am
- Alexza Pharmaceuticals Nears Daily High; Ready to Breakout - Benzinga 09.07.11 | 01:09 pm
- Alexza Hopes New NDA Submission Will Relieve Agitation - Benzinga 08.17.11 | 01:08 pm
